全文获取类型
收费全文 | 10688篇 |
免费 | 922篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 145篇 |
儿科学 | 386篇 |
妇产科学 | 196篇 |
基础医学 | 1530篇 |
口腔科学 | 157篇 |
临床医学 | 1043篇 |
内科学 | 2441篇 |
皮肤病学 | 141篇 |
神经病学 | 875篇 |
特种医学 | 575篇 |
外科学 | 1412篇 |
综合类 | 203篇 |
一般理论 | 3篇 |
预防医学 | 704篇 |
眼科学 | 316篇 |
药学 | 521篇 |
中国医学 | 9篇 |
肿瘤学 | 980篇 |
出版年
2021年 | 174篇 |
2020年 | 130篇 |
2019年 | 159篇 |
2018年 | 171篇 |
2017年 | 153篇 |
2016年 | 127篇 |
2015年 | 192篇 |
2014年 | 224篇 |
2013年 | 379篇 |
2012年 | 521篇 |
2011年 | 521篇 |
2010年 | 255篇 |
2009年 | 280篇 |
2008年 | 502篇 |
2007年 | 525篇 |
2006年 | 528篇 |
2005年 | 548篇 |
2004年 | 479篇 |
2003年 | 439篇 |
2002年 | 430篇 |
2001年 | 287篇 |
2000年 | 272篇 |
1999年 | 285篇 |
1998年 | 119篇 |
1997年 | 109篇 |
1996年 | 95篇 |
1995年 | 121篇 |
1994年 | 92篇 |
1993年 | 100篇 |
1992年 | 269篇 |
1991年 | 224篇 |
1990年 | 193篇 |
1989年 | 227篇 |
1988年 | 182篇 |
1987年 | 175篇 |
1986年 | 167篇 |
1985年 | 166篇 |
1984年 | 156篇 |
1983年 | 146篇 |
1982年 | 79篇 |
1981年 | 84篇 |
1980年 | 79篇 |
1979年 | 132篇 |
1978年 | 86篇 |
1977年 | 74篇 |
1976年 | 78篇 |
1973年 | 90篇 |
1972年 | 81篇 |
1971年 | 78篇 |
1968年 | 85篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献
2.
Christopher Teng JiaDe Yu Jesse Taylor Adam I. Rubin James R. Treat 《Pediatric dermatology》2019,36(5):697-701
Erosive pustular dermatosis of the scalp (EPDS) is an uncommon chronic inflammatory response to scalp trauma that usually resolves with cicatricial alopecia. It most commonly affects elderly patients with a history of actinic damage. Herein, we describe a 16‐year‐old girl with acrofacial dysostosis type 1 presenting after surgery with crusting purulent scalp lesions, whose clinical presentation and histopathologic findings were consistent with EPDS. A review of the literature on EPDS in children is also detailed. 相似文献
3.
4.
5.
6.
7.
Sebastian Bonner Thomas Matte Mitchell Rubin Joanne K Fagan Jennifer Ahern David Evans 《The Journal of asthma》2006,43(1):31-35
Although studies have documented underuse of controller medications and overuse of short-acting inhaled ss(2)-agonist among children with persistent asthma in disadvantaged communities, the persistence of oral ss(2)-agonist use in pediatric practice has not been studied since inhaled short-acting ss(2)-agonists became widespread. We describe medications used to treat asthma among children 3 to 5 years of age at 10 Head Start and other subsidized preschool centers in East and Central Harlem, New York City. We interviewed 149 parents/guardians of children who were identified as having probable asthma based on physician's diagnosis, persistent symptoms, hospitalization, and medication use. We classified 86 of the 149 children (58%) as having current persistent asthma. Only 15 of them (17%) were reported to have used controller medications at least 5 days/week in the last 4 weeks-only 2 of whom used inhaled corticosteroids. By contrast, 53 children (62%) used oral ss(2)-agonist in the last 4 weeks, often (72%) in conjunction with nebulized or inhaled short-acting ss(2)-agonist. Use of oral ss(2)-agonist was associated with more severe symptoms. This study documents the continued widespread use of oral ss(2)-agonist for treatment of children in a low-income community with high prevalence of asthma. 相似文献
8.
9.
10.
Mikael Hellström Bo Jacobsson Ulf Jodal Jan Winberg Anders Odén 《Pediatric nephrology (Berlin, Germany)》1987,1(3):269-275
This study presents the result of 12–21 years' follow-up in a group of children with neonatal urinary tract infection (onset within 1 month after birth) in whom early renal growth retardation was noted without concomitant classical renal scarring. In all cases the neonatal infection was diagnosed and treated within a few days of onset and the patients were closely supervised thereafter. Renal length, parenchymal thickness and area were measured at urography. At first follow-up (22 children, mean age 4.1 years) a significant reduction of renal parenchymal thickness was noted. Long-term follow-up (18 patients, mean age 17 years) demonstrated a normalization of renal size in the entire group, although less complete in the subgroup with reflux. There were two major findings in the present study. Firstly, renal growth retardation was seen after neonatal infection, both with and without reflux. Secondly, normalization of renal size in previously small kidneys was demonstrated, suggesting that growth retardation can be a reversible phenomenon. The tendency for such normalization was slightly more marked in children without reflux. Reduction of parenchymal thickness without calyceal deformity, therefore, does not necessarily mean irreversible damage, and differentiation between permanent scarring and temporary growth retardation can thus only be made at later follow-up, possibly not until after puberty. The demonstration of renal growth retardation in spite of early diagnosis and treatment emphasizes the great vulnerability of the kidney in the newborn. 相似文献